Price T Rowe Associates Inc. MD Buys 7,595 Shares of Chimera Investment Co. (NYSE:CIM)

Price T Rowe Associates Inc. MD boosted its position in Chimera Investment Co. (NYSE:CIM) by 10.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 78,703 shares of the real estate investment trust’s stock after acquiring an additional 7,595 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Chimera Investment were worth $1,102,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in CIM. New Age Alpha Advisors LLC purchased a new position in shares of Chimera Investment in the 4th quarter worth about $56,000. Hillsdale Investment Management Inc. purchased a new stake in Chimera Investment in the fourth quarter worth approximately $65,000. Summit Securities Group LLC bought a new position in Chimera Investment during the fourth quarter valued at approximately $111,000. Dynamic Technology Lab Private Ltd purchased a new position in shares of Chimera Investment during the fourth quarter worth approximately $170,000. Finally, Investment Partners Asset Management Inc. bought a new stake in shares of Chimera Investment in the 4th quarter worth approximately $183,000. Hedge funds and other institutional investors own 48.44% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on CIM shares. Royal Bank of Canada raised shares of Chimera Investment to a “moderate buy” rating in a report on Friday, March 14th. StockNews.com downgraded Chimera Investment from a “buy” rating to a “hold” rating in a report on Thursday, February 13th. Finally, JMP Securities restated a “market perform” rating on shares of Chimera Investment in a report on Thursday, January 23rd.

Chimera Investment Trading Down 1.3 %

NYSE:CIM opened at $12.63 on Friday. The firm has a market capitalization of $1.02 billion, a P/E ratio of 11.69 and a beta of 1.76. The company has a quick ratio of 3.03, a current ratio of 0.06 and a debt-to-equity ratio of 2.82. The company has a fifty day moving average of $12.40 and a 200 day moving average of $13.81. Chimera Investment Co. has a 52 week low of $9.85 and a 52 week high of $16.89.

Chimera Investment (NYSE:CIM) last issued its quarterly earnings data on Thursday, May 8th. The real estate investment trust reported $0.41 EPS for the quarter, beating the consensus estimate of $0.38 by $0.03. The firm had revenue of $69.22 million during the quarter, compared to the consensus estimate of $72.07 million. Chimera Investment had a net margin of 20.28% and a return on equity of 7.00%. On average, research analysts predict that Chimera Investment Co. will post 1.57 earnings per share for the current year.

Chimera Investment Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st were given a $0.37 dividend. The ex-dividend date was Monday, March 31st. This represents a $1.48 dividend on an annualized basis and a dividend yield of 11.72%. Chimera Investment’s dividend payout ratio is currently 137.04%.

Insider Activity

In related news, Director Gerard Creagh purchased 12,500 shares of the business’s stock in a transaction that occurred on Tuesday, March 11th. The shares were acquired at an average price of $13.31 per share, for a total transaction of $166,375.00. Following the completion of the acquisition, the director now directly owns 138,127 shares in the company, valued at approximately $1,838,470.37. The trade was a 9.95 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.91% of the company’s stock.

Chimera Investment Company Profile

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.